Surgical staging of uterine cancer: An analysis of perioperative morbidity

Surgical staging documented extrauterine disease in 27.9% of 168 patients with apparent early-clinical-stage uterine cancer. An analysis of operative time (78 ± 21 min), blood loss (332 ± 160 cc), and surgical site infection risks (4.7%) indicated little additional risk of lymphadenectomy. The long-...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 1991-09, Vol.42 (3), p.209-216
Hauptverfasser:	Orr, James W., Holloway, Robert W., Orr, Pamela F., Holimon, James L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Combined Modality Therapy Female Female genital diseases Gynecology. Andrology. Obstetrics Humans Hysterectomy - methods Intraoperative Period Lymph Node Excision Medical sciences Morbidity Neoplasm Recurrence, Local Neoplasm Staging Postoperative Complications Postoperative Period Surgical Wound Dehiscence Surgical Wound Infection Tumors Uterine Neoplasms - epidemiology Uterine Neoplasms - pathology Uterine Neoplasms - surgery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Surgical staging documented extrauterine disease in 27.9% of 168 patients with apparent early-clinical-stage uterine cancer. An analysis of operative time (78 ± 21 min), blood loss (332 ± 160 cc), and surgical site infection risks (4.7%) indicated little additional risk of lymphadenectomy. The long-term risk of lymphocyst (1.3%) or lymphedema (0.7%) was small. The histologic information obtained from staging was utilized to rationally guide the need for adjunctive teletherapy. The overall risk of recurrence (median follow-up, 26 months) with surgical Stage I disease was 2.6%.
ISSN:	0090-8258 1095-6859
DOI:	10.1016/0090-8258(91)90347-8